Tag: Small Pharma - Psychedelic Alpha

Our 2022 Year in Review is now live.

Read more about the article Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

Post published:March 7, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results

Small Pharma Announces Further Positive Data from SPL026 Phase IIa Trial in Major Depressive Disorder Strengthening Topline Efficacy Results

Post published:March 7, 2023
Post category:Press Release

Read more about the article Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference

Small Pharma to Present at Cowen’s 43rd Annual Health Care Conference

Post published:March 1, 2023
Post category:Press Release

Read more about the article First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial with SPL028

First Subject Dosed in Small Pharma’s First-in-Human Phase I Clinical Trial with SPL028

Post published:February 15, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue

Small Pharma Announces Update on Intellectual Property Portfolio with Two New Patents Approved for Issue

Post published:February 1, 2023
Post category:Press Release

Read more about the article Small Pharma Reports Fiscal Third Quarter 2023 Highlights

Small Pharma Reports Fiscal Third Quarter 2023 Highlights

Post published:January 25, 2023
Post category:Press Release

Read more about the article Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

Small Pharma Reports Positive Top-line Results from Phase IIa Trial of SPL026 in Major Depressive Disorder

Post published:January 25, 2023
Post category:Press Release

Read more about the article Small Pharma To Announce Results of SPL026 Phase IIa Trial for Major Depressive Disorder and Host Conference Call on Wednesday, January 25

Small Pharma To Announce Results of SPL026 Phase IIa Trial for Major Depressive Disorder and Host Conference Call on Wednesday, January 25

Post published:January 24, 2023
Post category:Press Release

Read more about the article First Patient Dosed in Small Pharma’s Phase I Study Exploring Intramuscular Administration of SPL026

First Patient Dosed in Small Pharma’s Phase I Study Exploring Intramuscular Administration of SPL026

Post published:January 15, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Completion of SPL026 Phase IIa Trial and Secures New Intellectual Property

Small Pharma Announces Completion of SPL026 Phase IIa Trial and Secures New Intellectual Property

Post published:December 24, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.